PDCD1 and neoplasm: In a separate study, NHS-muIL12 treatment of BALB/c mice bearing EMT6 breast tumors also increases PD-1 on CD4+ and CD8+ T cells and PD-L1 expression levels on tumor-associated macrophages, neutrophils and dendritic cells [26].